Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas

Απλή σελίδα τεκμηρίου
dc.contributor.authorValassiadou, K. E.en
dc.contributor.authorStefanaki, K.en
dc.contributor.authorTzardi, M.en
dc.contributor.authorDatseris, G.en
dc.contributor.authorGeorgoulias, V.en
dc.contributor.authorMelissas, J.en
dc.contributor.authorTsiftsis, D. D.en
dc.contributor.authorDelides, G.en
dc.contributor.authorKanavaros, P.en
dc.date.accessioned2015-11-24T19:11:56Z
dc.date.available2015-11-24T19:11:56Z
dc.identifier.issn0250-7005-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20984
dc.rightsDefault Licence-
dc.subjectAdenocarcinoma/*metabolismen
dc.subjectAdenoma/metabolismen
dc.subjectColon/metabolismen
dc.subjectColonic Neoplasms/*metabolismen
dc.subjectCyclin-Dependent Kinase Inhibitor p21en
dc.subjectCyclins/*metabolismen
dc.subjectHumansen
dc.subjectImmunoenzyme Techniquesen
dc.subject*Nuclear Proteinsen
dc.subjectProto-Oncogene Proteins/*metabolismen
dc.subjectProto-Oncogene Proteins c-bcl-2/*metabolismen
dc.subjectProto-Oncogene Proteins c-mdm2en
dc.subjectTumor Suppressor Protein p53/*metabolismen
dc.titleImmunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomasen
heal.abstractThe present study was undertaken to examine the distribution of p53, p21, mdm-2 and bcl-2 protein expression in human colorectal adenocarcinomas in order to obtain combined information about the immunophenotypes characterising these tumours. Formalin-fixed, paraffin-embedded tissue sections from 52 cases of colorectal adenocarcinomas were stained using immunohistochemical methods for the detection of p53, p21/waf1, mdm2 and bcl-2 proteins. P53, p21/waf1, mdm2 and bcl-2 proteins were expressed in 35/52, 45/52, 9/52 and 27/52 cases, respectively. All nine mdm2+ cases expressed p53 and p21 proteins as well. The three patterns observed in p53/p21 expression were: p53+/p21+, p53+/p21- and p53-/p21+ in 28, 7, and 17 cases, respectively. Consequently, p53+/mdm2-/p21+, p53+/mdm-/p21- and p53-/mdm2-/p21+ immunophenotypes were expressed in 19, 7, and 17 cases respectively. Four patterns of p53/bcl2 expression were identified: p53+/bcl2+, 20 cases; p53+/bcl2-, 15 cases; p53-/bcl2+, 7 cases; p53-/bcl2-, 10 cases. It was noteworthy that 9 of the 10 p53-/bcl2-tumours had negative lymph node status. The present results suggest that both p53 dependent and p53-independent induction of p21 expression may be involved in the molecular mechanisms controlling these tumours. High expression of the p53 protein in colorectal carcinomas could be due not only to p53 gene mutations but also to binding to mdm2 protein which leads to p53 protein stabilisation. In addition, tumours with p53-/bcl2- immunophenotype are frequently associated to negative lymph node status and seem to be less aggressive.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/9252682-
heal.journalNameAnticancer Resen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1997-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ